Pemgarda (pemivibart)

A New Option for COVID-19 Prevention

Protection for high-risk individuals

Schedule a Consultation

What is Pemgarda?

Pemgarda (pemivibart) is a groundbreaking monoclonal antibody infusion authorized by the FDA for pre-exposure prophylaxis of COVID-19 in immunocompromised individuals who may not mount an adequate immune response to COVID-19 vaccination.

How It Works

Pemgarda works by mimicking the immune system's ability to fight off pathogens. It specifically targets the spike protein of the SARS-CoV-2 virus, preventing it from entering human cells and causing infection.

Unlike vaccines that stimulate your immune system to create antibodies, Pemgarda provides immediate, targeted protection.

Who Can Benefit

Pemgarda is specifically designed for people with moderate-to-severe immune compromise due to medical conditions or immunosuppressive medications, including those with:

  • Cancer and hematologic malignancies
  • Organ or stem cell transplants
  • Advanced or untreated HIV infection
  • Primary immunodeficiencies
  • Autoimmune conditions requiring immunosuppressants

Effectiveness Against COVID-19

Proven Protection

Clinical trials have shown Pemgarda to be highly effective in preventing COVID-19 in immunocompromised individuals:

  • Reduction in symptomatic COVID-19
  • Maintains effectiveness against current variants
  • Protection begins immediately after infusion
  • Lasts for up to 3 months

Why Choose Pemgarda

For immunocompromised individuals who may not respond adequately to vaccines, Pemgarda offers:

  • Direct antibody protection
  • Immediate effectiveness
  • Long-lasting protection (up to 3 months)
  • Reduced risk of severe COVID-19 outcomes
  • Complementary to vaccination

The Treatment Process

What to expect when receiving Pemgarda at CarePoint

Step 1: Consultation

Meet with your docotor to determine if Pemgarda is right for you based on your medical history and current health status.

Step 2: Scheduling

Call our team and we will schedule your infusion at a convenient time at our facility.

Step 3: Preparation

Before your visit, we'll provide instructions to ensure a smooth experience.

Step 4: Infusion Day

The infusion takes approximately 60 minutes, followed by a 2-hour observation period for safety.

Step 5: Follow-up

We'll check in with you after your treatment to ensure your well-being and answer any questions.

Comfort & Care

Our infusion suites are designed for comfort with reclining chairs, warm blankets, and entertainment options.

Expert Team

We are specialize in monoclonal antibody therapies and provide personalized care throughout your visit.

Safety Protocols

We maintain strict safety measures including advanced air filtration and thorough sanitation between patients.

Frequently Asked Questions

Is Pemgarda a replacement for vaccination?

No, Pemgarda is not a replacement for COVID-19 vaccination. It is authorized as pre-exposure prophylaxis for individuals who are not expected to mount an adequate immune response to COVID-19 vaccination. Vaccination is still recommended for everyone eligible.

How long does protection from Pemgarda last?

Protection from Pemgarda lasts for up to 3 months. Patients may receive repeat doses every 6 months as needed for ongoing protection, based on their healthcare provider's recommendation.

What are the potential side effects?

Pemgarda is generally well-tolerated. The most common side effects include infusion-related reactions (which may include fever, chills, nausea, headache, shortness of breath, low or high blood pressure, wheezing, throat irritation, rash, hives, itching, muscle aches, and dizziness) and hypersensitivity reactions. Our medical team monitors patients closely during and after infusion to manage any reactions.

How much does Pemgarda cost?

Most insurance plans cover Pemgarda for eligible patients. Our financial counselors will work with you to verify coverage and discuss any potential out-of-pocket costs. We also offer assistance programs for eligible patients.

Can I receive Pemgarda if I've had COVID-19 recently?

Pemgarda is authorized for pre-exposure prophylaxis, meaning it's intended to prevent COVID-19 in people who have not been recently exposed. If you've had COVID-19 recently, please discuss the appropriate timing for Pemgarda with your healthcare provider.

Ready to Learn More About Pemgarda?

Contact CarePoint Infusion Center today to schedule a consultation

Phone: (216) 755-4044

Email: [email protected]

Address: 23215 Commerce Park Suite 318, Beachwood, OH 44122